Ahmad Mehdipour
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ahmad Mehdipour has a total of 91 co-authors. Here are the top co-authors by number of shared publications:
- Ali Samadikuchaksaraei
Department of Medical Biotechnology Faculty of Allied Medicine, Iran University of Medical Sciences Tehran Iran
5 shared publications - Amaneh Mohammadi Roushandeh
Department of Anatomy, School of Biomedical Sciences, Medicine & Health, UNSW Sydney, Sydney, NSW, 2052, Australia
3 shared publications - Mehryar Habibi Roudkenar
Burn and Regenerative Medicine Research Center, School of Medicine, Velayat Hospital, Guilan University of Medical Sciences, Rasht, Iran
3 shared publications - Mohammad Ebrahimi Kalan
Tabriz University of Medical Sciences
3 shared publications - Raheleh Halabian
Applied Microbiology Research Center, Biomedicine Technologies Institute Baqiyatallah University of Medical Sciences, Tehran, Iran
3 shared publications - Ayyub Ebrahimi
Molecular Biology and Genetics Haliç University Istanbul Turkey
2 shared publications
Latest Publications
- 27 June 2025
- Published by Wiley in Journal of Applied Polymer Science
- Vol. 142 (39)
Fabrication and Evaluation of PCL /Collagen I‐Based 3D Nanofibrous Scaffolds by Mold‐Assisted Electrospinning for Tissue Engineering and Regenerative Medicine
Three‐dimensional (3D) nanofibrous scaffolds exhibit superior biomimetic potential by structurally and functionally emulating the native extracellular matrix (ECM) microenvironment, a critical determinant for successful tissue repair and regeneration. While conventional two‐dimensional (2D) electrospun scaffolds provide nanoscale fibrous architectures, they do not have the necessary complexity to mimic cell–matrix interactions observed in vivo. This limitation is due to the current electrospinning methods, which mainly create flat structures instead of real 3D matrices that have controlled porosity and interconnectivity. This study developed a new method using a mold to produce three‐dimensional (3D) nanofibrous scaffolds made of polycaprolactone (PCL) and collagen type I (Col I) that mimic natural structures. For this purpose, a three‐dimensional aluminum template was engineered to directly fabricate nanofibrous scaffolds via electrospinning, bypassing supplementary processing stages. Subsequent comprehensive analysis encompassed physicochemical properties, biocompatibility, and critical performance metrics necessary for tissue engineering applications. Mold‐assisted electrospinning produced nanofibers (40–60 nm) and microfibers (0.2–0.7 μm). Porous scaffolds with nano‐ (200–500 nm) and micropores (15–25 μm) with high pore interconnectivity allow cell infiltration, migration, and nutrient/gas exchange. PCL/Col I nanofibrous scaffolds presented hydrophilic behavior, surface roughness and extended surface area, and favorable tensile strength and Young's modulus. PCL/collagen I‐based 3D nanofibrous scaffolds exhibited suitable cell attachment and a promoting effect on the proliferation and osteogenic differentiation of adipose‐derived mesenchymal stem cells (ADSCs). Osteogenic differentiation capability of cells on the nanofibrous scaffolds was analyzed by alkaline phosphatase activity and calcium content assay. Results showed higher alkaline phosphatase activity and calcium deposition mineralization than the 2D structures and control groups. These 3D constructs with admirable processability and compatibility with cells are promising candidates to be utilized as versatile platforms for tissue engineering.
- 27 June 2025
- Published by Wiley in Journal of Applied Polymer Science
- Vol. 142 (39)
Fabrication and Evaluation of PCL /Collagen I‐Based 3D Nanofibrous Scaffolds by Mold‐Assisted Electrospinning for Tissue Engineering and Regenerative Medicine
Three‐dimensional (3D) nanofibrous scaffolds exhibit superior biomimetic potential by structurally and functionally emulating the native extracellular matrix (ECM) microenvironment, a critical determinant for successful tissue repair and regeneration. While conventional two‐dimensional (2D) electrospun scaffolds provide nanoscale fibrous architectures, they do not have the necessary complexity to mimic cell–matrix interactions observed in vivo. This limitation is due to the current electrospinning methods, which mainly create flat structures instead of real 3D matrices that have controlled porosity and interconnectivity. This study developed a new method using a mold to produce three‐dimensional (3D) nanofibrous scaffolds made of polycaprolactone (PCL) and collagen type I (Col I) that mimic natural structures. For this purpose, a three‐dimensional aluminum template was engineered to directly fabricate nanofibrous scaffolds via electrospinning, bypassing supplementary processing stages. Subsequent comprehensive analysis encompassed physicochemical properties, biocompatibility, and critical performance metrics necessary for tissue engineering applications. Mold‐assisted electrospinning produced nanofibers (40–60 nm) and microfibers (0.2–0.7 μm). Porous scaffolds with nano‐ (200–500 nm) and micropores (15–25 μm) with high pore interconnectivity allow cell infiltration, migration, and nutrient/gas exchange. PCL/Col I nanofibrous scaffolds presented hydrophilic behavior, surface roughness and extended surface area, and favorable tensile strength and Young's modulus. PCL/collagen I‐based 3D nanofibrous scaffolds exhibited suitable cell attachment and a promoting effect on the proliferation and osteogenic differentiation of adipose‐derived mesenchymal stem cells (ADSCs). Osteogenic differentiation capability of cells on the nanofibrous scaffolds was analyzed by alkaline phosphatase activity and calcium content assay. Results showed higher alkaline phosphatase activity and calcium deposition mineralization than the 2D structures and control groups. These 3D constructs with admirable processability and compatibility with cells are promising candidates to be utilized as versatile platforms for tissue engineering.
- Open Access
- 14 April 2025
- Published by Maad Rayan Publishing Company in Immunopathologia Persa
- Vol. 11 (2) , e41735
Exploring the therapeutic potential of Cerebrolysin-loaded exosomes in multiple sclerosis; an experimental study on neuroprotection and immune modulation
Introduction: Multiple sclerosis (MS) is a complex immune-mediated disorder of the central nervous system (CNS) characterized by inflammation and degeneration, currently lacking a cure. The blood-brain barrier (BBB) challenges of delivery of therapeutic agents to affected neural tissues. Exosomes, with low-immunogenicity and the ability to cross biological barriers, offer a promising avenue for targeted delivery of neurotrophic factors (NTFs) to support neuronal survival and regeneration. This study investigated the therapeutic potential of stem cell-derived exosomes (SCDEs) and Cerebrolysin-loaded exosomes (CLE) in an experimental autoimmune encephalomyelitis (EAE) model, a preclinical paradigm for MS. Objectives: The co-delivery of NTFs and exosomes aimed to modulate the immune response and promote remyelination and neuroprotection in EAE. Materials and Methods: An EAE modeling was induced in C57BL/6 mice in an experimental study, treated with SCDE, CBL, or CLE by intraperitoneal administration. Assessments included clinical scoring, gene expression analysis in splenocytes, and cytokine quantification. Results: Results showed that the CLE group exhibited significant improvement in behavioral manifestations compared to SCDE and CBL groups. CLE treatment stimulated survival signaling pathways, influencing EAE progression, and suppressed pro-inflammatory transcription factors while upregulating anti-inflammatory factors in splenocytes. CLE significantly reduced pro-inflammatory cytokine interferon-gamma (IFN‐γ) in serum samples, suggesting a neuroprotective effect by targeting pathways and overcoming BBB limitations. Conclusion: The observed immune modulation and neural protection in the CLE group suggest its potential for MS treatment. Further investigations are needed to elucidate mechanisms and explore clinical applications. The study highlights the promise of CLE-based therapy in addressing MS pathology.
- 14 April 2025
- Published by Maad Rayan Publishing Company in Immunopathologia Persa
- Vol. 11 (2) , e41735
Open AccessExploring the therapeutic potential of Cerebrolysin-loaded exosomes in multiple sclerosis; an experimental study on neuroprotection and immune modulation
Introduction: Multiple sclerosis (MS) is a complex immune-mediated disorder of the central nervous system (CNS) characterized by inflammation and degeneration, currently lacking a cure. The blood-brain barrier (BBB) challenges of delivery of therapeutic agents to affected neural tissues. Exosomes, with low-immunogenicity and the ability to cross biological barriers, offer a promising avenue for targeted delivery of neurotrophic factors (NTFs) to support neuronal survival and regeneration. This study investigated the therapeutic potential of stem cell-derived exosomes (SCDEs) and Cerebrolysin-loaded exosomes (CLE) in an experimental autoimmune encephalomyelitis (EAE) model, a preclinical paradigm for MS. Objectives: The co-delivery of NTFs and exosomes aimed to modulate the immune response and promote remyelination and neuroprotection in EAE. Materials and Methods: An EAE modeling was induced in C57BL/6 mice in an experimental study, treated with SCDE, CBL, or CLE by intraperitoneal administration. Assessments included clinical scoring, gene expression analysis in splenocytes, and cytokine quantification. Results: Results showed that the CLE group exhibited significant improvement in behavioral manifestations compared to SCDE and CBL groups. CLE treatment stimulated survival signaling pathways, influencing EAE progression, and suppressed pro-inflammatory transcription factors while upregulating anti-inflammatory factors in splenocytes. CLE significantly reduced pro-inflammatory cytokine interferon-gamma (IFN‐γ) in serum samples, suggesting a neuroprotective effect by targeting pathways and overcoming BBB limitations. Conclusion: The observed immune modulation and neural protection in the CLE group suggest its potential for MS treatment. Further investigations are needed to elucidate mechanisms and explore clinical applications. The study highlights the promise of CLE-based therapy in addressing MS pathology.
- Open Access
- 4 April 2024
- Published by Elsevier in Chemical Engineering Journal
- Vol. 489
Engineered bioadhesive Self-Healing nanocomposite hydrogel to fight infection and accelerate cutaneous wound healing
- 4 April 2024
- Published by Elsevier in Chemical Engineering Journal
- Vol. 489
Open AccessEngineered bioadhesive Self-Healing nanocomposite hydrogel to fight infection and accelerate cutaneous wound healing
- Open Access
- 1 November 2023
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- Vol. 14 (6) , 813-826
Co-exposure to Toluene and Noise Made Synergistic and Antagonistic Effects on Some Neurotoxic Parameters in New Zealand White Rabbits
Introduction: Numerous physical and chemical agents can induce destructive effects on the brain tissue. Noise and toluene, which are some of these harmful agents, have significant adverse effects on the brain tissue. This work aimed to investigate the neurotoxic changes induced by co-exposure to toluene and noise. Methods: A total of ...
- 1 November 2023
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- Vol. 14 (6) , 813-826
Open AccessCo-exposure to Toluene and Noise Made Synergistic and Antagonistic Effects on Some Neurotoxic Parameters in New Zealand White Rabbits
Introduction: Numerous physical and chemical agents can induce destructive effects on the brain tissue. Noise and toluene, which are some of these harmful agents, have significant adverse effects on the brain tissue. This work aimed to investigate the neurotoxic changes induced by co-exposure to toluene and noise. Methods: A total of ...
- Open Access
- 7 April 2023
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 14 (1) , 1-21
Application of mesenchymal stem cell sheet for regeneration of craniomaxillofacial bone defects
Bone defects are among the most common damages in human medicine. Due to limitations and challenges in the area of bone healing, the research field has turned into a hot topic discipline with direct clinical outcomes. Among several available modalities, scaffold-free cell sheet technology has opened novel avenues to yield efficient osteogenesis. It is suggested that the intact matrix secreted from cells can provide a unique microenvironment for the acceleration of osteoangiogenesis. To the best of our knowledge, cell sheet technology (CST) has been investigated in terms of several skeletal defects with promising outcomes. Here, we highlighted some recent advances associated with the application of CST for the recovery of craniomaxillofacial (CMF) in various preclinical settings. The regenerative properties of both single-layer and multilayer CST were assessed regarding fabrication methods and applications. It has been indicated that different forms of cell sheets are available for CMF engineering like those used for other hard tissues. By tackling current challenges, CST is touted as an effective and alternative therapeutic option for CMF bone regeneration.
- 7 April 2023
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 14 (1) , 1-21
Open AccessApplication of mesenchymal stem cell sheet for regeneration of craniomaxillofacial bone defects
Bone defects are among the most common damages in human medicine. Due to limitations and challenges in the area of bone healing, the research field has turned into a hot topic discipline with direct clinical outcomes. Among several available modalities, scaffold-free cell sheet technology has opened novel avenues to yield efficient osteogenesis. It is suggested that the intact matrix secreted from cells can provide a unique microenvironment for the acceleration of osteoangiogenesis. To the best of our knowledge, cell sheet technology (CST) has been investigated in terms of several skeletal defects with promising outcomes. Here, we highlighted some recent advances associated with the application of CST for the recovery of craniomaxillofacial (CMF) in various preclinical settings. The regenerative properties of both single-layer and multilayer CST were assessed regarding fabrication methods and applications. It has been indicated that different forms of cell sheets are available for CMF engineering like those used for other hard tissues. By tackling current challenges, CST is touted as an effective and alternative therapeutic option for CMF bone regeneration.
- 3 February 2022
- Published by Taylor & Francis in International Journal of Polymeric Materials and Polymeric Biomaterials
- Vol. 72 (9) , 665-680
A review of recent advances on osteogenic applications of Silk fibroin as a potential bio-scaffold in bone tissue engineering
Silk fibroin (SF) have been increasingly used as bone substitutes in tissue engineering (TE) due to their sufficient mechanical strength, good biocompatibility, osteoconductive, and controllable degradation rates. The SF scaffold as a 3D-matrix allows and stimulates the proliferation, attachment and differentiation of stem cells toward osteogenic cells. Herein, we have summarized the applications of SF for regeneration of bone defects in a comprehensive manner. Additionally, we have discussed three critical factors for osteogenesis regulation, including biological (cells and growth factors), physical (mechanics and morphology), and chemical (composition) aspects with their current drawbacks and future perspective of SF in bone TE. Graphical Abstract
- 3 February 2022
- Published by Taylor & Francis in International Journal of Polymeric Materials and Polymeric Biomaterials
- Vol. 72 (9) , 665-680
A review of recent advances on osteogenic applications of Silk fibroin as a potential bio-scaffold in bone tissue engineering
Silk fibroin (SF) have been increasingly used as bone substitutes in tissue engineering (TE) due to their sufficient mechanical strength, good biocompatibility, osteoconductive, and controllable degradation rates. The SF scaffold as a 3D-matrix allows and stimulates the proliferation, attachment and differentiation of stem cells toward osteogenic cells. Herein, we have summarized the applications of SF for regeneration of bone defects in a comprehensive manner. Additionally, we have discussed three critical factors for osteogenesis regulation, including biological (cells and growth factors), physical (mechanics and morphology), and chemical (composition) aspects with their current drawbacks and future perspective of SF in bone TE. Graphical Abstract
- 12 July 2021
- Published by Taylor & Francis in Journal of Medical Engineering & Technology
- Vol. 45 (7) , 511-531
The efficiency of PCL/HAp electrospun nanofibers in bone regeneration: a review
Electrospinning is a method which produces various nanofiber scaffolds for different tissues was attractive for researchers. Nanofiber scaffolds could be made from several biomaterials and polymers. Quality and virtues of final scaffolds depend on used biomaterials (even about single substance, the origin is effective), additives (such as some molecules, ions, drugs, and inorganic materials), electrospinning parameter (voltage, injection speed, temperature, …), etc. In addition to its benefits, which makes it more attractive is the possibility of modifications. Common biomaterials in bone tissue engineering such as poly-caprolactone (PCL), hydroxyapatite (HAp), and their important features, electrospinning nanofibers were widely studied. Related investigations indicate the critical role of even small parameters (like the concentration of PCL or HAp) in final product properties. These changes also, cause deference in cell proliferation, adhesion, differentiation, and in vivo repair process. In this review was focussed on PCL/HAp based nanofibers and additives that researchers used for scaffold improvement. Then, reviewing properties of gained nanofibers, their effect on cell behaviour, and finally, their valency in bone tissue engineering studies (in vitro and in vivo).
- 12 July 2021
- Published by Taylor & Francis in Journal of Medical Engineering & Technology
- Vol. 45 (7) , 511-531
The efficiency of PCL/HAp electrospun nanofibers in bone regeneration: a review
Electrospinning is a method which produces various nanofiber scaffolds for different tissues was attractive for researchers. Nanofiber scaffolds could be made from several biomaterials and polymers. Quality and virtues of final scaffolds depend on used biomaterials (even about single substance, the origin is effective), additives (such as some molecules, ions, drugs, and inorganic materials), electrospinning parameter (voltage, injection speed, temperature, …), etc. In addition to its benefits, which makes it more attractive is the possibility of modifications. Common biomaterials in bone tissue engineering such as poly-caprolactone (PCL), hydroxyapatite (HAp), and their important features, electrospinning nanofibers were widely studied. Related investigations indicate the critical role of even small parameters (like the concentration of PCL or HAp) in final product properties. These changes also, cause deference in cell proliferation, adhesion, differentiation, and in vivo repair process. In this review was focussed on PCL/HAp based nanofibers and additives that researchers used for scaffold improvement. Then, reviewing properties of gained nanofibers, their effect on cell behaviour, and finally, their valency in bone tissue engineering studies (in vitro and in vivo).
- Open Access
- 1 April 2019
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 112, 108663
Somatic cell reprogramming as a tool for neurodegenerative diseases
- 1 April 2019
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 112, 108663
Open AccessSomatic cell reprogramming as a tool for neurodegenerative diseases
- 1 June 2018
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 102, 9-17
Telomerase activity and telomere on stem progeny senescence
- 1 June 2018
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 102, 9-17
Telomerase activity and telomere on stem progeny senescence
- 1 July 2017
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 91, 88-94
Regulation and roles of CD26/DPPIV in hematopoiesis and diseases
- 1 July 2017
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 91, 88-94
Regulation and roles of CD26/DPPIV in hematopoiesis and diseases